Status:
UNKNOWN
Impact of the Decrease of Exposure to Hypnosedative Drugs in the Elderly Through the Discontinuation of Hospital-initiated Prescription
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Pierre and Marie Curie University
Conditions:
Sleep Disorders
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
Brief Summary Context. Sleep disorders complaints are common in elderly and hypnosedative drugs are widely prescribed in community-dwelling elderly. Furthermore, acute hospitalisation may induce slee...
Detailed Description
Context Hypnosedative prescriptions in hospital can be either the continuation of the drug already prescribed before admission or result from an initiation during hospitalization. In the hospitalised...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients hospitalized in one of the investigation centres
- Individuals (male and female) aged 65 years and above
- Patients prescribed an hypnosedative drug during the hospitalization (after the first 48 hours)
- Patients from whom a non-opposition of participation in the research is obtained
- Patients with no history of hypnosedative at the admission (and during the first 48 hours of hospitalization)
- Individuals not suffering from cognitive impairment suggested by a score of less than 24 on the Mini-Mental State Examination
- Patients returning home at discharge
- Patients reachable by phone
- Exclusion criteria
- Patients who gave their opposition to participate in the study
- Patient with physical disability
- Patients suffering from severe depression with suicide risk or other severe psychopathologic conditions
- Individuals suffering from cognitive impairment suggested by a score of less than 24 on the Mini-Mental State Examination
- Patients suffering from metastatic/terminal cancer or undergoing parenteral treatment (cytotoxic or targeted therapy) for cancer or in palliative care program
- Patients with severe alcohol or drug dependence
- Patients unable to answer a questionnaire in French
- Patients unable to undergo the intervention
- Patients not available by phone at discharge
- Patients not returning home at discharge
Exclusion
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2017
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT02296957
Start Date
November 1 2014
End Date
October 1 2017
Last Update
October 10 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique Hopitaux de Paris - Hopital Saint Antoine
Paris, France, 75012